Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWellSpan Health

About this trial

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism.

The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE.

The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Eligibility criteria

Qualifiers

Age >= 18 years of age

ED diagnosis of acute pulmonary embolism with identification on CT imaging

Disqualifiers

Age <18 years of age

Inability to provide informed consent

Incarceration

Current PE previously diagnosed prior to index ED visit

Trial design

Treatments tested in this trial

  • Point-of-care echocardiography

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators

WellSpan Health

Lead sponsor

Stony Brook University

Collaborator

University of California, Irvine

Collaborator